East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg. Aurobindo Pharma’s Prochlorperazine Maleate Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Compazine Tablets manufactured by GlaxoSmithKline (GSK)

Prochlorperazine Maleate Tablets are indicated:

• For control of severe nausea and vomiting.
• For the treatment of schizophrenia.
• For the short-term treatment of generalized non-psychotic anxiety.